Cargando…
Anticoagulant therapy in COVID‐19: A narrative review
Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including coagulopathy and thrombosis. These complications can be the first and sometimes only manifestations of SARS‐CoV‐2 infection and can occur ea...
Autores principales: | Mohseni Afshar, Zeinab, Tavakoli Pirzaman, Ali, Hosseinzadeh, Rezvan, Babazadeh, Arefeh, Taghizadeh Moghadam, Mohamad Ali, Miri, Seyed Rouhollah, Sio, Terence T., Sullman, Mark J. M., Barary, Mohammad, Ebrahimpour, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499427/ https://www.ncbi.nlm.nih.gov/pubmed/37326220 http://dx.doi.org/10.1111/cts.13569 |
Ejemplares similares
-
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2023) -
A review of the potential neurological adverse events of COVID-19 vaccines
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022) -
Challenges posed by COVID‐19 in cancer patients: A narrative review
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2021) -
Clinical misdiagnosis of influenza infection with a confusing clinical course: A case report
por: Babazadeh, Arefeh, et al.
Publicado: (2023) -
Non-arteritic anterior ischemic optic neuropathy as an atypical feature of COVID-19: A case report
por: Babazadeh, Arefeh, et al.
Publicado: (2022)